HypertensionNCT06743191

Delivering a Digital Health Intervention to Improve Food Access and Dietary Quality Among Adults With Hypertension

A study testing Access Nourish in people with Hypertension, run by Johns Hopkins University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

Who is it for?: Ages 18 years and older
Conditions the study is for: Hypertension
What is being tested?: Access Nourish
Type of treatment: Lifestyle or therapy programme
Could I receive a placebo?: No, everyone receives an active treatment
How many people: 67 participants
Where: 1 siteUnited States
Study dates: 27 Feb 2025to 18 Dec 2025
Phase: Interventional
Are there results?: Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 18 years and older
All sexes
No healthy volunteers
Adult, Older adult

Who may be able to join

Adult 18 years of age or older
Has hypertension, defined as a systolic BP of 130-159 mmHg and/or diastolic BP of 80-99 mmHg, whether or not taking hypertension medication.
Resides in a census tract defined as low access by the United States Department of Agriculture (USDA)
Resides in a zip code serviced by the grocery delivery app
BMI 18.5 kg/m2+
Has a smartphone with a data plan

Show all 9Show fewer

Willing to receive daily text messages
Can participate in online videoconference visits
Can read and write in English

Who cannot join

Participating in another related research study
Cardiovascular disease event in the last 6 months
Active cancer
Recent hospitalization due to psychiatric condition or event
Pregnancy or planned during the study period
BMI 37 kg/m2 or higher

Show all 10Show fewer

Documented dementia
On kidney dialysis
Instructed to eat a low potassium diet
Planned or recent bariatric surgery

Trial locations and contacts

1 site in 1 country.

United States1 site

Johns Hopkins
Baltimore, Maryland, 21205

Other trials in United States

About this study

Official title: Feasibility of Delivering a Digital Health Intervention to Improve Food Access and Dietary Quality Among Adults With Hypertension

A total of 65 participants with hypertension and low access to high quality food will be enrolled to test the feasibility of using commercially available grocery delivery services, simultaneous to a robust behavioral intervention, to improve adherence to the Dietary Approaches to Stop Hypertension (DASH) eating pattern. The behavioral intervention will include skills training, nutrient goal setting, self-monitoring via dietary tracking, personalized text message feedback, and adaptive health coaching. Participants will also receive a membership to an online grocery delivery service and weekly grocery list recommendations from a health coach. The primary outcome will be indicators of feasibility, including acceptability, demand, implementation and practicality and adaption. Change in DASH adherence and blood pressure will also be evaluated. The intervention period for participants will be 4 months.

Conditions: Hypertension
Being tested: Access Nourish
Keywords: Digital Health, Health Behavior, Nutrition, Hypertension, Food Access
Medical subject headings: Hypertension, Health Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Access NourishBehavioural
A total of 65 participants with hypertension and low access to high quality food will be enrolled to test the feasibility of using commercially available grocery delivery services, simultaneous to a robust behavioral intervention, to improve adherence to the DASH eating pattern. The behavioral intervention will include skills training, nutrient goal setting, self-monitoring via dietary tracking, personalized text message feedback, and adaptive health coaching. Participants will also receive a membership to an online grocery delivery service and weekly grocery list recommendations from a health coach. Participants will be able to complete all intervention components via smartphone. The intervention period for participants will be 4 months.

Study groups in NCT06743191
Study group	Role	What they receive
Assess the feasibility of Access Nourish in a 4-month study among adults with hypertension li	Experimental	All participants will be prospectively assigned to receive a behavioral intervention that includes skills training, nutrient goal setting, self-monitoring via dietary tracking, personalized text message feedback, and adaptive health coaching. Participants will also receive a membership to an online grocery delivery service and weekly grocery list recommendations from a health coach. All intervention will be delivered remotely using smartphone technology. Receives: Behavioral: Access Nourish

What is being measured

The primary outcome is the main question the study is designed to answer.

Feasibility Assessed by Survey
Feasibility will be assessed via participant accrual, participant retention, and other indicators of feasibility by survey adapted from Bowen et al, including acceptability, demand, implementation, practicality, and adaptation of the intervention. The score scale ranged from 1-5, where 1 was strongly disagree and 5 was strongly agree.
Measured: 4 Months

Secondary outcomes (3)

DASH Score as Assessed by the Automated Self-Administered 24-hour (ASA24)
Participants will enter dietary intake online via the National Cancer Institute's Automated Self-Administered 24-hour (ASA24) Dietary Assessment tool. DASH dietary nutrients are then converted into a score. Scores ranged from 0 to 9 where a higher score indicates better adherence to the DASH dietary pattern.
Measured: Baseline, 2 months, and 4 months
Systolic Blood Pressure
Systolic blood pressure will be measured in millimeters of mercury (mmHg) using the upper arm three times at 1-minute intervals after 5 minutes of quiet sitting. The final 2 measurements will be averaged together for analysis.
Measured: Baseline and 4 months
Diastolic Blood Pressure
Diastolic blood pressure will be measured in millimeters of mercury (mmHg) using the upper arm three times at 1-minute intervals after 5 minutes of quiet sitting. The final 2 measurements will be averaged together for analysis.
Measured: Baseline and 4 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

27 Feb 202518 Dec 2025

First posted19 Dec 2024
Study start27 Feb 2025
Primary completion18 Dec 2025
Study completion18 Dec 2025

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
Other trials for HypertensionStudies of the same condition, open and under way.
More trials run by Johns Hopkins UniversityThe sponsor's other registered studies.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Interventional
Phase: Phase N/A
Primary purpose: Prevention
Allocation: Not applicable
Intervention model: Single group
Masking: None (open label)
Enrolment: 67 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT06743191
Sponsor's protocol ID: IRB00447049
Other IDs: R21NR021041
Status last verified: Oct 2026
First submitted: 16 Dec 2024
Last updated: 3 Nov 2026
Results posted: Yes, on ClinicalTrials.gov
Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No
Individual data sharing: No

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Not yet recruitingPhase 2/3
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Enrolling by invitation
Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle
Pregnancy Related, Hypertension

All Hypertension trials

Study at a glance

From the registry record, last updated by the sponsor on 3 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: Feasibility of Delivering a Digital Health Intervention to Improve Food Access and Dietary Quality Among Adults With Hypertension
ClinicalTrials.gov ID: NCT06743191
Acronym / sponsor ID: IRB00447049
Conditions: Hypertension
Keywords: Digital Health, Health Behavior, Nutrition, Hypertension, Food Access
Study type: Interventional
Recruitment status: Completed
Enrolment: 67 participants (actual)
Lead sponsor: Johns Hopkins UniversityUniversity, hospital or other
Collaborators: National Institute of Nursing Research (NINR)
Study start: 27 Feb 2025 (actual)
Primary completion: 18 Dec 2025 (actual)
Study completion: 18 Dec 2025 (actual)
First posted: 19 Dec 2024 (actual)
Results: Posted 3 Nov 2026

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

Study design

Primary purpose: Prevention
Allocation: Not applicable
Intervention model: Single group
Masking: None (open label)
Number of arms: 1

Arm	Type	Receives
Assess the feasibility of Access Nourish in a 4-month study among adults with hypertension li	Experimental	Behavioral: Access NourishAll participants will be prospectively assigned to receive a behavioral intervention that includes skills training, nutrient goal setting, self-monitoring via dietary tracking, personalized text message feedback, and adaptive health coaching. Participants will also receive a membership to an online grocery delivery service and weekly grocery list recommendations from a health coach. All intervention will be delivered remotely using smartphone technology.

Who may qualify

Ages: 18 years and older
Sex: All
Healthy volunteers: Not accepted
Age groups: Adult, Older adult

Key inclusion criteria (9 listed)

Adult 18 years of age or older
Has hypertension, defined as a systolic BP of 130-159 mmHg and/or diastolic BP of 80-99 mmHg, whether or not taking hypertension medication.
Resides in a census tract defined as low access by the United States Department of Agriculture (USDA)
Resides in a zip code serviced by the grocery delivery app
BMI 18.5 kg/m2+

Key exclusion criteria (10 listed)

Participating in another related research study
Cardiovascular disease event in the last 6 months
Active cancer
Recent hospitalization due to psychiatric condition or event
Pregnancy or planned during the study period

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Interventions

Intervention	Type	Arms
Access NourishA total of 65 participants with hypertension and low access to high quality food will be enrolled to test the feasibility of using commercially available grocery delivery services, simultaneous to a robust behavioral intervention, to improve adherence to the DASH eating pattern. The behavioral intervention will include skills training, nutrient goal setting, self-monitoring via dietary tracking, personalized text message feedback, and adaptive health coaching. Participants will also receive a membership to an online grocery delivery service and weekly grocery list recommendations from a health coach. Participants will be able to complete all intervention components via smartphone. The intervention period for participants will be 4 months.	Behavioural	Assess the feasibility of Access Nourish in a 4-month study among adults with hypertension li

Primary outcome

Feasibility Assessed by Survey
Time frame: 4 Months
Feasibility will be assessed via participant accrual, participant retention, and other indicators of feasibility by survey adapted from Bowen et al, including acceptability, demand, implementation, practicality, and adaptation of the intervention. The score scale ranged from 1-5, where 1 was strongly disagree and 5 was strongly agree.

3 secondary outcomes

DASH Score as Assessed by the Automated Self-Administered 24-hour (ASA24)
Time frame: Baseline, 2 months, and 4 months
Systolic Blood Pressure
Time frame: Baseline and 4 months
Diastolic Blood Pressure
Time frame: Baseline and 4 months

Results and safety

Results posted to the registry on 3 Nov 2026, as reported by the sponsor. Figures are copied from the record, not re-analysed. Full results on ClinicalTrials.gov.

Participant flow

Group	Started	Completed
Access Nourish Behavioral Intervention	67	66

Primary outcome: Feasibility Assessed by Survey

Time frame: 4 Months. Mean (Standard Deviation). Unit: score on a scale

Measure	Access Nourish Behavioral Intervention n = 64
Participating in the study was doable, given my location and schedule.	4.33 (0.89)
Participating in Access Nourish improved my access to DASH-friendly foods.	3.98 (1.09)
Participating in Access Nourish helped me make healthier food choices.	4.38 (0.77)
I enjoyed receiving grocery lists with food suggestions for the DASH diet.	3.83 (1.11)
It was easy to access the grocery lists provided by the health coach.	4.45 (0.80)
The grocery lists aligned with my dietary preferences.	3.77 (1.00)
The grocery lists encouraged me to try new foods.	3.87 (1.11)
The grocery lists included items that fit within my budget.	4.18 (0.98)

Population analysed: Participants with data collected

3 secondary outcomes are reported in the full results.

Adverse events

Time frame: Enrollment to 4 months. Other adverse events reported at 0% frequency or more

Group	Serious adverse events	Other adverse events	Deaths
Access Nourish Behavioral Intervention	0 of 67 (0%)	2 of 67 (3%)	0 of 67

Loading the posted results from ClinicalTrials.gov…

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 3 Nov 2026.
Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Individual participant dataSharing planned: No

Related trials for Hypertension

Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Not yet recruitingPhase 2/3
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Enrolling by invitation
Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle
Pregnancy Related, Hypertension

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

Hailey N Miller, RN, PhD principal investigator

Johns Hopkins University

Gary G Bennett, PhD principal investigator

Duke University

1 site in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

A study testing Access Nourish in people with Hypertension, run by Johns Hopkins University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 3 Nov 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility Assessed by Survey (time frame: 4 Months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06743191.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2026.